Literature DB >> 1433117

Botulinum toxin treatment of spasmodic torticollis.

T J Anderson1, J Rivest, R Stell, M J Steiger, H Cohen, P D Thompson, C D Marsden.   

Abstract

We reviewed the efficacy and adverse effects of repeated botulinum toxin injections into hyperactive neck muscles of 107 successive patients with spasmodic torticollis. They received 510 injection treatments over a median period of 15 months (range 3-42 months). One patient failed to benefit at all, but 101 (95%) patients reported considerable (moderate or excellent) benefit from at least one treatment. On a global subjective response rating, 93% of 429 treatments resulted in some improvement and 76% in moderate or excellent improvement. Pain reduction followed 89% of 190 treatments with moderate or excellent reduction after 66%. Median duration of benefit was 9 weeks. All torticollis types responded equally well and injections into two (or more) involved neck muscles were more effective than injection into a single muscle. The most frequent adverse effect was dysphagia, occurring after 44% of all treatments, but this was severe after only 2%. Antibodies to botulinum toxin were detected in the serum of three out of the five patients in whom loss of treatment efficacy occurred. We conclude that botulinum toxin treatment is the most effective available therapy for spasmodic torticollis and practical advice is provided for anyone wishing to set up the technique.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433117      PMCID: PMC1293637     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  14 in total

1.  Botulinum toxin injections for cervical dystonia.

Authors:  J Jankovic; K Schwartz
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

2.  Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis.

Authors:  P Greene; U Kang; S Fahn; M Brin; C Moskowitz; E Flaster
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

3.  Outbreak of botulism in north west England and Wales, June, 1989.

Authors:  E M Critchley; P J Hayes; P E Isaacs
Journal:  Lancet       Date:  1989-10-07       Impact factor: 79.321

4.  Botulinum toxin in torticollis.

Authors:  R Stell; P D Thompson; C D Marsden
Journal:  Neurology       Date:  1989-10       Impact factor: 9.910

5.  Double-blind study of botulinum toxin in spasmodic torticollis.

Authors:  J K Tsui; A Eisen; A J Stoessl; S Calne; D B Calne
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

6.  Neuromuscular effects distant from the site of botulinum neurotoxin injection.

Authors:  R K Olney; M J Aminoff; D J Gelb; D H Lowenstein
Journal:  Neurology       Date:  1988-11       Impact factor: 9.910

Review 7.  Mesencephalic haematoma: case report with autopsy study.

Authors:  A de Mendonça; J Pimentel; F Morgado; J M Ferro
Journal:  J Neurol       Date:  1990-02       Impact factor: 4.849

8.  125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection.

Authors:  H Wiegand; G Erdmann; H H Wellhöner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

9.  Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis.

Authors:  D J Gelb; D H Lowenstein; M J Aminoff
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

10.  Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves.

Authors:  J D Black; J O Dolly
Journal:  J Cell Biol       Date:  1986-08       Impact factor: 10.539

View more
  21 in total

Review 1.  Uses of botulinum toxin injection in medicine today.

Authors:  A Münchau; K P Bhatia
Journal:  BMJ       Date:  2000-01-15

Review 2.  Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity.

Authors:  Christopher Dowson; Mohammad Shamim Khan; Prokar Dasgupta; Arun Sahai
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

3.  Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases.

Authors:  A M Bakheit; C D Ward; D L McLellan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

4.  The role of pallidum in the neural integrator model of cervical dystonia.

Authors:  Alexey Sedov; Svetlana Usova; Ulia Semenova; Anna Gamaleya; Alexey Tomskiy; J Douglas Crawford; Brian Corneil; H A Jinnah; Aasef G Shaikh
Journal:  Neurobiol Dis       Date:  2019-01-22       Impact factor: 5.996

5.  Prospective study of swallowing function in patients with cervical dystonia undergoing selective peripheral denervation.

Authors:  A Münchau; C D Good; S McGowan; N P Quinn; J D Palmer; K P Bhatia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-07       Impact factor: 10.154

Review 6.  Dystonia.

Authors:  Ailsa Snaith; Derick Wade
Journal:  BMJ Clin Evid       Date:  2014-02-28

Review 7.  Dystonia.

Authors:  Ailsa Snaith; Derick Wade
Journal:  BMJ Clin Evid       Date:  2011-06-13

8.  Localised autonomic failure due to botulinum toxin injection.

Authors:  K O Bushara
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

9.  Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure.

Authors:  Dirk Dressler; Hans Bigalke
Journal:  J Neurol       Date:  2005-03-11       Impact factor: 4.849

10.  Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.

Authors:  G L Sheean; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.